Literature DB >> 2296599

Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells.

J M Wilson1, O Danos, M Grossman, D H Raulet, R C Mulligan.   

Abstract

Recombinant retroviruses encoding human adenosine deaminase (ADA; adenosine aminohydrolase, EC 3.5.4.4) have been used to infect murine hematopoietic stem cells. In bone marrow transplant recipients reconstituted with the genetically modified cells, human ADA was detected in peripheral blood mononuclear cells of the recipients for at least 6 months after transplantation. In animals analyzed in detail 4 months after transplantation, human ADA and proviral sequences were detected in all hematopoietic lineages; in several cases, human ADA activity exceeded the endogenous activity. These studies demonstrate the feasibility of introducing a functional human ADA gene into hematopoietic stem cells and obtaining expression in multiple hematopoietic lineages long after transplantation. This approach should be helpful in designing effective gene therapies for severe combined immunodeficiency syndromes in humans.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296599      PMCID: PMC53279          DOI: 10.1073/pnas.87.1.439

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Expression of human adenosine deaminase in murine hematopoietic cells.

Authors:  J W Belmont; G R MacGregor; K Wager-Smith; F A Fletcher; K A Moore; D Hawkins; D Villalon; S M Chang; C T Caskey
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

3.  Human adenosine deaminase. Distribution and properties.

Authors:  M B Van der Weyden; W N Kelley
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

4.  Molecular form of adenosine deaminase in severe combined immunodeficiency.

Authors:  M B Van der Weyden; R H Buckley; W N Kelley
Journal:  Biochem Biophys Res Commun       Date:  1974-04-08       Impact factor: 3.575

5.  The nucleotide sequence of the chick cytoplasmic beta-actin gene.

Authors:  T A Kost; N Theodorakis; S H Hughes
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic retroviruses.

Authors:  R S McIvor; M J Johnson; A D Miller; S Pitts; S R Williams; D Valerio; D W Martin; I M Verma
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

8.  Comparison of myeloproliferative sarcoma virus with Moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis.

Authors:  A Stacey; C Arbuthnott; R Kollek; L Coggins; W Ostertag
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

9.  Human hypoxanthine-guanine phosphoribosyltransferase. Demonstration of structural variants in lymphoblastoid cells derived from patients with a deficiency of the enzyme.

Authors:  J M Wilson; B W Baugher; P M Mattes; P E Daddona; W N Kelley
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

10.  Selective overproduction of adenosine deaminase in cultured mouse cells.

Authors:  C Y Yeung; D E Ingolia; C Bobonis; B S Dunbar; M E Riser; M J Siciliano; R E Kellems
Journal:  J Biol Chem       Date:  1983-07-10       Impact factor: 5.157

View more
  24 in total

Review 1.  Gene therapy.

Authors:  S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

2.  Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells.

Authors:  V W van Beusechem; A Kukler; P J Heidt; D Valerio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Dynamic DNA methylation and histone modifications contribute to lentiviral transgene silencing in murine embryonic carcinoma cells.

Authors:  Jin He; Qing Yang; Lung-Ji Chang
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Retroviral-mediated gene transfer into hepatocytes in vivo.

Authors:  N Ferry; O Duplessis; D Houssin; O Danos; J M Heard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

5.  Expression of a swine class II gene in murine bone marrow hematopoietic cells by retroviral-mediated gene transfer.

Authors:  G E Shafer; D W Emery; K Gustafsson; S Germana; W F Anderson; D H Sachs; C LeGuern
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 6.  Prospects for homologous recombination in human gene therapy.

Authors:  M A Vega
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

Review 7.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

8.  Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells.

Authors:  D M Bodine; K T McDonagh; S J Brandt; P A Ney; B Agricola; E Byrne; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  An in vivo animal model of gene therapy for leukocyte adhesion deficiency.

Authors:  J C Krauss; L A Mayo-Bond; C E Rogers; K L Weber; R F Todd; J M Wilson
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

10.  The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction.

Authors:  D Orlic; L J Girard; C T Jordan; S M Anderson; A P Cline; D M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.